According to our new research report titled “ Generic Drug Market in Canada”, Canada has witnessed rapidly increasing need and demand for generic drug sales through hospital pharmacies, owing to government support through cost reduction measures. The rapid growth in sales through retail pharmacies will be driven by the entry of large number of banner pharmacies and rising investment by existing players. The size of generic drug through retail pharmacies is likely to grow by around CAD 8 Billion by 2014, growing at an impressive CAGR of around 12% during 2010-2014.
The need and demand for generic drugs in Canada has witnessed continual growth over the last few years, owing to Patent expiration of branded drugs, rapidly aging population and the government support through cost reduction measures. According to a latest report by RNCOS, fast growth in aging population transformed in increasing prescription rates. Surging penetration of generic drug due to their low costs and government’s various reimbursement plans has constructed a suitable platform for generic drug market growth.
The report, “ Generic Drug Market in Canada”, provides an in-depth research and rational analysis of the current status and expected position of the generic drugs in Canada. It facilitates the future forecasts of the sales by various segments, like by province, distribution channels, and by diseases during 2011-2014. Additionally, analysis of the regulatory environment along with recent industry developments has been included in the report to provide a balanced outlook on the potentials of the Canada generic drug market.
Some of our Related Reports are as follows:
- Cancer Generics Market Analysis
- Booming Generics Drug Market in India
- UK Generics Market Analysis
- Japanese Generic Market Forecast to 2013
- Booming US Generic Drug Market
|
